<--- Back to Details
First PageDocument Content
Protein kinase inhibitors / Piperidines / Lymphoma / Carlo Gambacorti-Passerini / Anaplastic large-cell lymphoma / Clinical medicine / Chemistry / Anaplastic lymphoma kinase / Cancer / ALK inhibitor / Passerini / Brigatinib
Date: 2015-10-05 11:40:28
Protein kinase inhibitors
Piperidines
Lymphoma
Carlo Gambacorti-Passerini
Anaplastic large-cell lymphoma
Clinical medicine
Chemistry
Anaplastic lymphoma kinase
Cancer
ALK inhibitor
Passerini
Brigatinib

Add to Reading List

Source URL: erialcl.net

Download Document from Source Website

File Size: 168,76 KB

Share Document on Facebook

Similar Documents

Protein kinase inhibitors / Piperidines / Lymphoma / Carlo Gambacorti-Passerini / Anaplastic large-cell lymphoma / Clinical medicine / Chemistry / Anaplastic lymphoma kinase / Cancer / ALK inhibitor / Passerini / Brigatinib

PDF Document

DocID: 1npVD - View Document

Protein kinase inhibitors / Piperidines / Anaplastic lymphoma kinase / Lymphoma / Lung cancer / ALK inhibitor / Anaplastic large-cell lymphoma / Crizotinib / Non-small-cell lung carcinoma / ALK / Ceritinib / Carlo Gambacorti-Passerini

Early Stage researcher (ESR) PhD Projects ESR 1 Investigation of the nuclear functions of ALK Duration: 3 years Start: before August 2016

DocID: 1mHtD - View Document

Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer PosterHendrik-Tobias Arkenau,1 Jasgit C. Sachdev

DocID: 1lzQ3 - View Document

Circulating tumor cell / Oncology / Non-small-cell lung carcinoma / ALK inhibitor / Anaplastic lymphoma kinase / Staining / Medicine / Lung cancer / Anatomical pathology

Cambridges Healthtech InstituteĀ“s 22th International Molecular Med Tri-Con 2015 San Francisco, Feb 2015 Enumeration and ALK investigation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients using a

DocID: 1gnav - View Document

Circulating tumor cell / Oncology / Non-small-cell lung carcinoma / ALK inhibitor / Anaplastic lymphoma kinase / Staining / Medicine / Lung cancer / Anatomical pathology

Cambridges Healthtech InstituteĀ“s 22th International Molecular Med Tri-Con 2015 San Francisco, Feb 2015 Enumeration and ALK investigation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients using a

DocID: 1abrR - View Document